drugset / Trial / NCT00830648
Safety of a Second Dose of Biken's Varicella Vaccine
NaSingle-groupOpen-labelPrevention
Summary
The objective of the present study is to assess and document the safety of a second dose of Varicella Biken vaccine administered at 4 to 6 years of age in healthy children having previously received a first dose of Varicella Biken vaccine. All subjects will receive a second dose of Varicella vaccine (Varicella Biken) at 4 to 6 years of age. The expected total duration of follow-up (first visit to last visit) for each subject will be one month.
Timeline
- Start
- 2009-01
- Primary completion
- 2009-10
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Live Attenuated Varicella Virus Vaccine | Vaccine | 0.5 ml | Subcutaneous |